Are there any human studies of BPC-157?
Small early-phase reports exist but no published controlled safety or efficacy trial. Every frequency figure you see for BPC-157 side effects online is invented.
No controlled human trial — rodent toxicology plus mechanism; no frequency figures exist
BPC-157 has an unusually large animal literature and no controlled human safety trial. Rodent studies report no toxicity at the doses used, but that is not human data. The concerns worth stating are mechanistic: it promotes angiogenesis and modulates nitric-oxide signalling, and in 2023 the FDA placed it in Category 2 of its bulk-substance review citing insufficient safety information.
Research-use information only. Research-grade BPC-157 is not an approved medicine; where trial or label figures appear below they belong to the pharmaceutical product studied, not to any research vial. This page does not give dosing or medical advice.
Every rate carries its source. Where no source exists, no rate is printed.
| Effect | Rate (sourced) | Detail | Source |
|---|---|---|---|
| Rodent toxicology | not quantified | No lethal dose reached and no organ toxicity reported in the Sikiric group's studies; interpret as animal data from a single group. | Sikiric et al. (reviews, 2011–2020) |
| Injection-site reactions | not quantified | The one effect that can be expected from any subcutaneous peptide; not quantified for BPC-157. | General |
Regulatory status: Not approved anywhere. FDA placed BPC-157 in Category 2 (insufficient safety data) of its 503A bulk-substance evaluation in September 2023.
Everything above describes BPC-157 the molecule. The risk specific to a research vial is different: it may not contain BPC-157 at the labelled amount, and it may contain what the synthesis left behind. Identity (mass spectrometry), purity (HPLC), measured net content and an endotoxin result are the four lines on a certificate that bear on adverse effects, and only a certificate you can check at the laboratory tells you any of them. This is what we have verified for BPC-157 so far.
53 of the 77 vendors on our scoreboard list BPC-157 with a price we read on the product page (5 Sept 2026–2 Oct 2026). Of those, 46 name their testing laboratory, 36 publish certificates that resolve on the lab's own site, and 43 publish measured milligrams against the label. The full ranking, with every dated price, is on Best BPC-157 Vendors.
| Vendor | Rubric | Lab named | Price read |
|---|---|---|---|
| MyPurePeptidepartner | 10/10 | Janoshik Analytical | $25.00 · 10mg · 30 Sept 2026 |
| Peptide Giantspartner | 10/10 | Janoshik Analytical · Vanguard Laboratory | $36.00 · 10mg · 2 Oct 2026 |
| Purgo Labspartner | 10/10 | SteriGenix · Freedom Diagnostics | $44.99 · 10mg · 2 Oct 2026 |
| Ameano Peptidespartner | 9/10 | Janoshik Analytical | $44.00 · 10mg · 2 Oct 2026 |
| Amino Clubpartner | 9/10 | ILS Labs | $39.99 · 10mg · 2 Oct 2026 |
Top 5 by rubric score; 48 more on the ranking page.
50 certificates for BPC-157 in the COA library: 14 checkable on the laboratory's own site, 43 stating measured mass against the label, 44 carrying a flag.
Small early-phase reports exist but no published controlled safety or efficacy trial. Every frequency figure you see for BPC-157 side effects online is invented.